- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 10 - Drivers of Cost in Cardiometabolic Management
During this segment, the panelists discuss the highest drivers of cost when managing cardiometabolic disease. Michael Weber, MD, explains that adverse events cause costs to rise dramatically and Kenneth L. Schaecher, MD, FACP, CPC, clarifies the fact that from a managed care standpoint, the greatest proportion of dollars are spent on inpatient services.
David Calabrese, RPh, MHP, claims that 70% of the dollars spent today are used to manage factors associated with diabetes, including cardiovascular comorbidities, and explains that the dollars are used to try to prevent other negative sequalae from occurring down the road.
Additionally, the panelists explain that the topic of the costs associated with cardiometabolic management is controversial. Dr Schaecher explains that preventing cardiometabolic events can be more expensive than treating an event on a firsthand basis due to the costs of drugs for the treatment of long-term conditions, or risk factors.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
